Y-mAbs Therapeutics, Inc. Uncategorized Contracts & Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Consultancy Agreement, entered into on July 16, 2024, between Investeringsselskabet GH ApS and the Company
Y-mAbs Therapeutics, Inc.
Biotechnology
2024
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934
Y-mAbs Therapeutics, Inc.
Biotechnology
2024
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934
Y-mAbs Therapeutics, Inc.
Biotechnology
2023
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934
Y-mAbs Therapeutics, Inc.
Biotechnology
2022
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934
Y-mAbs Therapeutics, Inc.
Biotechnology
2021
Master Sponsored Research Agreement effective as of October 7, 2020 by and between the Company and Memorial Sloan Kettering Cancer Center
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2020
Description of the registrants securities registered pursuant to section 12 of the Securities Exchange Act of 1934
Y-mAbs Therapeutics, Inc.
Biotechnology
2020
Y-mAbs Sublicense Agreement, dated as of June 27, 2018, by and between the Company and MabVax Therapeutics Holdings, Inc
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2019
Amended and Restated Sponsored Research Agreement effective as of September 13, 2019 by and between the Company and Memorial Sloan Kettering Cancer Center
Y-mAbs Therapeutics, Inc.
Biotechnology
NY
2019